• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Disturbance in the pediatric patients with intractable epilepsy-severe myoclonic epilepsy in infants

Research Project

Project/Area Number 09670819
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionOita Medical University

Principal Investigator

IZUMI Tatsuro  Oita Medical University, School of Medicine, Professor, 医学部, 教授 (80119891)

Co-Investigator(Kenkyū-buntansha) MAEDA Tomoki  Oita Medical University, School of Medicine, Associate, 医学部, 助手 (80264349)
SATO Keisuke  Oita Medical University, School of Medicine, Associate, 医学部, 助手 (40295176)
FUKUSHIMA Naoki  Oita Medical University, School of Medicine, Associate, 医学部, 助手 (60218914)
IMAI Kazuhide  Oita Medical University, School of Medicine, Associate, 医学部, 助手 (50295177)
Project Period (FY) 1997 – 1999
KeywordsIntractable epilepsy in children / Severe myoclonic epilepsy in infants / HLA antigen / maternal in heritance / neuronal maturation distarbance / gangliosides / neuroepithelial tumor / breast milk
Research Abstract

Severe myoclonic epilepsy infants (SME) is a recently defined syndrome (Dravet et al, 1982). Their characteristics are very homogeneous: family history of epilepsy or febrile convulsions, no previous personal history of disease, seizures beginning during the first year of life which are very resistant to all forms of treatment, and all the children affected suffer from intellectural deficiency. A high percentage of family history for epilepsy or convulsions was noted. A more accurate genetic analysis, however, is not examined, and impossible because the type of epilepsy in the family is not indicated in detail and accurately.
Now we examined seizure types, EEG findings and HLA typing of 5 patients in 4 families with SME and their family members.
In 3 families, maternal members had febrile conculsions and epilepsy, two mothers by themselves and a moternal aunt. The patients with SME and their mothers shared common HLA antigen A24(9). But this HLA antigen A29(9) may not be statistically sp … More ecific, which is commonly detected in our Japanese. The possibility of moternal transmission and maternal anticipation should be elucidated in a near future.
To elucidate a relationship between neuronal anaplasia, prematurity, neuroepithelial tumor proliferation, and ganglioside contents, we quantified gangliosides by HPTLC in tomors of neuroblastoma.(NB, grade IV), and dysembryoplastic neuroepithelial tumor(DNT, grade I). PPNET, the mostundifferentiated tumor examined had lowest concentration of total lipid-bound sialic acid. GM 3 was the major ganglioside in all undifferentiated tumors (46-72.7% of total lipid-bound sialic acid). GD3 was an another component in PPNET and EPEN(7.2-17.3%). Concentration of a complex gangliosides GM1 was decreased in all tumor cissues and those of GT1a, GD1b and GT1b were decreased in tumors of high grade. The results suggest that the composition of gangliosides could be of considerable value in refining the classification of neuorepithelial tumors in infancy and childhood.
The ganglioside compositions of human milk, cow's milk and infant formulas were compared. The results showed that there was a drastic change in the ganglioside composition from the colostrum to later human milk, and that both the patterns and contents of gangliosides in human milk, cow's milk and infant formulas differed markedly. In human milk, the total lipid-bound sialic acid level was two times higher than those in cow's milk and infant formulas. The major ganglioside in the later human milk, GM 3 (27.7%), was only a minor component in the colostrum, cow's milk and infant formulas (3.3%, 2.8% and 0.4-2.6%, respectively). GD3 represented 49.0%, 61.0% and 72.4-86.6%, respectively, of the colostrum, cow's milk and infant formulas, compared to 31.8% of the later human milk gangliosides. The variation of the gangliosides in human and cow's milk, and infant formulas might have some biological significance regarding neonatal brain development, allergies, infant growth and non-immunoglobulin prophylactic activities against some bacterial toxins. Less

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Ikawa K, Morikawa N, Eshima N, Izumi T, Takeyama M.: "Evaluation of clonazepam pharmacokinetics in epileptic children receiving monotherapy or polytherapy, and the influences of concomitant antiepileptic drugs on the serum concentration of clonazepam"Jpn J hosp Pharm. 24. 130-135 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kojo M, yamada K, Izumi T.: "Normal developmental changes in carotis artery diameter measured by Echo-Tracking"Pediatric Neurology. 18. 221-226 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Pan XL, Izumi T.: "Chronological changes in the ganglioside composition of human milk during lactation"Early Human Development. 55. 1-8 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikawa K, Eshima N, Morikawa N, Kawashima H, Izumi T, Takeyama M.: "Influence of concomitant anticovulsants on serum concentrations of clonazepam in epileptic subjects: An age- and dose-effect linear regression model analysis"Pharm. Pharmacol. Commun.. 5. 307-310 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Pan XL, Izumi T.: "Variation of the ganglioside compositions of fuman milk, cow's milk and infant formulas"Early Hum Develop. 57. 25-37 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Pan XL, Izumi T, Yamada H, Akiyoshi K, Suenobu S, Yokoyama S,: "Ganglioside patterns in neuroepithelial tumors of childhood"Brain Dev. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Izumi T, Matsuda M, Ohga Y, maeda T, Fukushima N, Pan XL, naebaq E.: "In new developments in child neurology"Clinico-neuroradiological findings and paternal CAG repeat expansion in a family of Huntington disease. 143-147 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikawa K, Morikawa N, Eshima N, Izumi T, Takeyama M.: "Evaluation of clonazepam pharmacokinetics in epileptic children receiving monotherapy or polytherapy, and the influences of concomitant antiepileptic drugs on the serum concentration of clonazepam"Jpn J Hosp Pharm. 24. 130-135 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kojo M, Yamada K, Izumi T: "Normal developmental changes in carotid artery diameter measured by Echo-Tracking"Pediatric neurology. 18. 221-226 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Pan XL, Izumi T: "Chronological changes in the ganglioside composition of human milk during lactation"Early Human Development. 55. 1-8 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikawa K, Eshima N, Morikawa N, Kawashima H, Izumi T, Takeyama M: "Influence of concomitant anticonvulsants on serum concentrations of clonazepam in epileptic subjects: An age-and dose-effect linear regression model analysis"Pharm Parmacol. Commun. 5. 307-310 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Pan XL, Izumi T: "Variation of the ganglioside compositions of human milk, cow's milk and infant formulas"Early Hum Develop 2000. 57. 25-31 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Pan XL, Izumi T, Yamada H, Akiyoshi K, Suenobu S, Yokoyama S: "Granglioside patterns in neuroepithelial tumers of childhood"Brain Dev.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Izumi T, Matsuda M, Ohga Y, Maeda T, Fukushima N, Pan XL, Nanba E: "Clinico-neuroradiological findings and paternal CAG repeat expansion in a family of Huntington disease"In new developments in child neurology. Ed. Perat MV, Monduzzi Editore, Bologna (Italy). 143-147 (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi